A Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of a Specialized Pro-Resolving Mediator Formulation on Inflammation in Individuals Who Are Overweight to Mildly Obese and Otherwise Generally Healthy
Sponsor: Supplement Formulators, Inc.
Terminated
COVID-19 pandemic
Other terminated trials from Supplement Formulators, Inc.
More terminations from Supplement Formulators, Inc.
This NA trial investigates Inflammation and Inflammatory Response and is currently terminated or withdrawn. Supplement Formulators, Inc. leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Feb 2023 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Nov 2022 — Feb 2023 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Active Not Recruiting NA
▶ Show 2 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Mar 2020 — Nov 2020 [monthly]
Recruiting NA
First recorded
Oct 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Supplement Formulators, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .